May 5, 2025
Trump chooses chloroquina defender to take up US management against pandemics
Steven Hatfill promoveu uso do medicamento contra malária para tratar Covid-19 mesmo sem evidências de eficácia
Read More
Apr 30, 2025
Paxlovid Filed for Pediatric Label Expansion in Japan: Pfizer
Pfizer Japan said on April 28 that it has filed its oral COVID-19 treatment Paxlovid (nirmatrelvir/ritonavir) for a wider label to include its use in children six years of age and older who weigh at least 20 kg.
Read More
Apr 30, 2025
New antiviral compounds show broad protection against COVID-19 variants
Novel Mpro inhibitors exhibit broad activity against SARS-CoV-2 and other coronaviruses.
Read More